TPIDB > Principal Investigator
Principal Investigator
更新時間：2023-09-19
李宜家LEE, YI-CHIA
- Co-Principal Investigator
- Clinical Trial Experience (year) 17 years 9 個月
Publication
23Publications
21
Iwabu J, Yamashita S, Takeshima H, Kishino T, Takahashi T, Oda I, Koyanagi K, Igaki H, Tachimori Y, Daiko H, Nakazato H, Nishiyama K, Lee YC, Hanazaki K, Ushijima T. FGF5 methylation is a sensitivity marker of esophageal squamous cell carcinoma to definitive chemoradiotherapy. Sci Rep. 2019 Sep 16;9(1):13347. doi: 10.1038/s41598-019-50005-6. PMID: 31527639; PMCID: PMC6746740.
22
Yang MH, Chen SC, Lin YF, Lee YC, Huang MY, Chen KC, Wu HY, Lin PC, Gozes I, Tyan YC. Reduction of aluminum ion neurotoxicity through a small peptide application - NAP treatment of Alzheimer's disease. J Food Drug Anal. 2019 Apr;27(2):551-564. doi: 10.1016/j.jfda.2018.11.009. Epub 2019 Jan 12. PMID: 30987727.
23
Jen HH, Wang TH, Chiu HM, Peng SM, Hsu CY, Chiu SY, Chen SL, Yen AM, Lee YC, Chen HH, Fann JC. Hurdle Poisson Regression Model for Identifying Factors Related to Noncompliance and Waiting Time for Confirmatory Diagnosis in Colorectal Cancer Screening. Int J Technol Assess Health Care. 2019 Jan;35(2):85-91. doi: 10.1017/S0266462319000047. Epub 2019 Mar 1. PMID: 30819270.
